Market Tracker

10/31 7:05pm ET

Response Genetics Inc (NASDAQ:RGDX)

0.7647
Data as of Oct 31
 +0.0647 / +9.24%
Today’s Change
0.51
Today|||52-Week Range
2.22
-34.08%
Year-to-Date

Today’s Trading

Previous close0.70
Today’s open0.76
Day’s range0.69 - 0.78
Volume50,393
Average volume (3 months)91,872
Market cap$27.1M
Dividend yield--
Data as of 10/31/2014

Growth & Valuation

Earnings growth (last year)+17.24%
Earnings growth (this year)+20.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+5.68%
P/E ratio--
Price/Sales1.96
Price/Book4.71

Competitors

 Today’s
change
Today’s
% change
DMPIDelMar Pharmaceutica...+0.03+3.29%
CBLICleveland Biolabs In...+0.02+3.06%
OPXAOpexa Therapeutics I...-0.01-0.99%
CTRVContraVir Pharmaceut...+0.18+16.22%
Data as of 10/31/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$19.8M
Annual profit (last year)-$8.0M
Net profit margin-40.50%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Thomas A. Bologna
Chief Financial Officer &
Vice President
Kevin Roy Harris
Corporate headquarters
Los Angeles, California

Forecasts